Suki is making waves in the healthcare sector, recently partnering with Rush to deploy its AI technology across 28 specialties. This collaboration aims to integrate Suki's dictation capabilities into electronic health records, enhancing clinician workflows. Additionally, Suki has teamed up with Wolters Kluwer Health to incorporate clinical decision support content into its platform.
Suki's AI solutions are gaining traction, with over 350 health systems adopting its technology. The company differentiates itself from competitors by providing a platform for other tech firms to develop their AI advancements. As the market becomes increasingly competitive, Suki's focus on seamless integration and clinician usability positions it well for future growth.
• Suki partners with Rush to enhance healthcare technology integration.
• Microsoft launches Dragon Copilot, a competitor in AI healthcare solutions.
Suki is described as an AI assistant that helps clinicians with various tasks.
Suki integrates clinical decision support content to aid clinicians at the point of care.
Suki's technology includes ambient scribing, allowing for seamless documentation during patient interactions.
Suki provides AI solutions that enhance clinical workflows and documentation processes in healthcare.
Microsoft's Dragon Copilot combines voice dictation and ambient listening for healthcare applications.
The Cornell Daily Sun 7month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
